Verona Pharma Plc

This study tested a new inhaled medicine that combines two drugs (ensifentrine and glycopyrrolate) for people with chronic obstructive pulmonary disease (COPD). The main goal was to see how the body absorbs and processes the combination compared to each drug alone, and to check i…

This study tested a new inhaled medication called glycopyrrolate for people with Chronic Obstructive Pulmonary Disease (COPD). Forty-six participants tried three different doses and a placebo over several weeks to see how well it improved their breathing. The main goal was to mea…